The short answer
Review kava before combining it with fluphenazine because guidance cautions against use with sedating substances. The exact pair’s added impairment has not been measured, and a safe spacing interval is not established.
What this answer covers
Oral fluphenazine with the exact supplement preparation described.
- Supplement or preparation
- Piper methysticum
- Medication ingredient
- fluphenazine
The concern is overlapping impairment
Fluphenazine can cause drowsiness or impair performance. Kava guidance advises against combining it with sedating substances, which supports checking the combination rather than treating a botanical as automatically mild.
A small trial did not find driving impairment from kava alone
Twenty-two adults received kava, oxazepam and placebo in separate sessions. The tested kava preparation did not significantly impair simulated driving compared with placebo; the oxazepam condition affected selected measures.
Separate sessions are not a combination test
Participants did not take kava with fluphenazine in that trial. Its result cannot supply a safe combined dose, quantify respiratory effects or establish that kava increases the medicine’s blood level. Products and other sedating medicines can differ.
Review the actual products
Bring the supplement label and your full medication list to the pharmacist, especially if fluphenazine already affects alertness. Avoid driving when sleepy or impaired. No supplement dose or short spacing interval has been established to prevent overlapping effects.
Evidence and practical considerations
Side effects & toxicity
Review kava before combining it with fluphenazine because guidance cautions against use with sedating substances. The exact pair’s added impairment has not been measured, and a safe spacing interval is not established.
- Exact scope
- Oral fluphenazine with the exact supplement preparation described. with Oral fluphenazine with the stated label and formulation limits.
- Medication form and route
- oral
What remains uncertain
- Conditional alertness precaution from the exact medicine label and kava guidance. The standalone driving-null result is retained. No exact event rate, additive liver-injury estimate or protective interval was established; the timing proposition remains insufficiently supported.
Factors that may matter: Exact preparation and amount; Other medicines; Seizure history, alertness or electrolyte status where relevant.
Read the supporting source summaries
Source 1: Current U.S. regulatory product labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral fluphenazine.
May cause drowsiness or lethargy. Hypotension is not usually a problem but can occur. Atropine and similar agents may potentiate anticholinergic activity. Caution with seizure history.
How this applies: Exact ingredient and oral-route clinical context.
Label class warnings do not establish every exact botanical interaction, event rate or protective supplement interval.
Source 2: Federal supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering the named botanical or supplement.
Advises against combining kava with other sedating substances. Products vary and separate liver-injury concerns are described.
How this applies: Supports a sedation precaution, not a demonstrated exact-pair respiratory or liver injury rate.
General guidance does not quantify this exact medication combination or establish a universal protective interval.
Source 3: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twenty-two adults in a crossover driving-simulator trial.
Kava did not significantly impair driving compared with placebo; oxazepam impaired selected measures.
How this applies: Contrary standalone finding does not establish co-use safety.
Separate conditions, not simultaneous use. One product and dose, no target medication.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked draft with exact preparation limits, original study findings and uncertainty. Clinical review not recorded. | |
| Research summary published |
Article revision: f0776241162a0035
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.